Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.

Ana PalancaCarmen Quinones-TorreloJuan GirbésJosé T RealF Javier Ampudia-Blasco

Published in: European journal of clinical investigation (2022)

COVID-19 restriction measures affected HbA1c testing. During complete lockdown, HbA1c testing decreased by half across all gender and age groups. No deleterious effect on glycaemic control was observed during lockdown and post-lockdown among those tested.

Keyphrases

coronavirus disease
sars cov
type diabetes
cardiovascular disease
metabolic syndrome
respiratory syndrome coronavirus
adipose tissue